Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer

Jyoti D. Patel, Thomas A. Hensing, Alfred Rademaker, Eric M. Hart, Matthew G. Blum, Daniel T. Milton, Philip D. Bonomi

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences